Business

Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity

Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity Written by: prnewswire.comOriginal Article  NEW YORK, Jan. 12, 2023 /PRNewswire/ — Versanis Bio (“Versanis”), a clinical-stage biopharmaceutical company advancing novel …

Versanis Announces Initiation of the BELIEVE Global Phase 2b Study of Bimagrumab as a Novel Treatment for Obesity Read More »